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2015;8:885–8.Atrial Fibrillation Is an
Obesity-Related Outcome,
Requiring a Body
Composition-Neutral
Assessment of
Cardiorespiratory FitnessWe read with interest the study by Pathak et al. (1) of
the role of exercise in the care of obese patients with
atrial ﬁbrillation (AF). The authors demonstrated
convincingly the compound beneﬁt of an “alliance
of cardiorespiratory ﬁtness with weight-loss” in pre-
venting recurrence of AF. We accept the validity of
the main conclusion but want to point out that the
ﬁtness test used cannot discriminate between effects
of ﬁtness gain and weight loss.
As stated recently, the treadmill protocol used for
estimating ﬁtness is likely to introduce a bias
against obese individuals (2). Brieﬂy, the most ac-
curate test of cardiorespiratory ﬁtness is direct
measurement of oxygen consumed in a maximal
exercise test. The indirect treadmill test that was
used in the current study is a simpliﬁed protocol for
clinical use (1). As in all weight-bearing forms of
exercise, obese individuals are at a disadvantage as
they have to carry more weight in the form of fat
that does not contribute to exercise performance.
Thus, other things being equal, the more obese
subjects will be exhausted earlier and their ﬁtness
estimated lower. Correction of a similar body
composition bias required appreciation of ﬁtness
estimates with increasing obesity by 17% to 39% (3).
In the current study, it is impossible to establish
whether ﬁtness can compensate for fatness as the
measure of ﬁtness (treadmill time) in itself is a
function of both ﬁtness and fatness.We fully agree with the authors that both weight
loss and physical exercise are essential components
of risk management in overweight and obese sub-
jects: Advocating a ﬁtness-ﬁrst approach (4), based on
treadmill test results similar to those in the current
study, might mislead the general public into turning a
blind eye to the importance of simultaneous dietary
weight management.*Benno Krachler, MD, PhD, MS
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382–90.REPLY: AtrialFibrillation IsanObesity-Related
Outcome, Requiring a Body
Composition-Neutral Assessment of
Cardiorespiratory FitnessWe thank Drs. Krachler and Lindahl for highlighting
some of the key ﬁndings of the CARDIO-FIT
(CARDIOrespiratory FITness on Arrhythmia Recur-
rence in Obese Individuals With Atrial Fibrillation)
study. This study demonstrated that, in overweight
and obese individuals with symptomatic atrial ﬁbril-
lation (AF), preserved baseline cardiorespiratory
ﬁtness (CRF) improves long-term freedom from AF.
Gain in CRF had a synergistic and additive effect on
weight loss in improving long-term outcome of AF (1).
The study determined CRF by using a commonly per-
formed, highly reproducible, and well-validated
“symptom limited treadmill test” (2). It is acknowl-
edged that metabolic equivalent (METs) calculation
and peak O2 consumption (gold standard) can vary
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350with body mass index (BMI), and we acknowledge
concerns Krachler et al. mentioned regarding the
possible error in calculating METs in obese patients
during load-bearing exercise, in particular when
comparing normal weight patients with obese pa-
tients. However, in the CARDIO-FIT study, the mean
BMI was not different between the CRF groups at
baseline and could not have resulted in a selection or
ascertainment bias. We are therefore conﬁdent that, in
the absence of any between-group differences in BMI,
our study ﬁndings remain valid regardless of the
measurement used to score CRF.
Another seminal ﬁnding of the study was the effect
of CRF gain on AF outcome. Individuals who gained
CRF of$2METs had signiﬁcantly greater weight loss. A
previous study showed minor difference in the degree
of underestimation of peak METs for each 5-unit
change in BMI (3). In our study, the mean weight loss
in the $2 MET gain group was 3.9 kg/m2 and was un-
likely to have resulted in signiﬁcant alteration in
the MET measurement. A gain of $2 MET in CRF was
associated with 2-fold greater freedom from AF. This
gainwas above the beneﬁt conferred by theweight loss
alone in these patients, highlighting the prescriptive
role of exercise in managing patients with AF.
Finally, the CARDIO-FIT study emphasizes the
importance of incremental beneﬁt of gain in CRF
through a structured exercise program along with
weight-loss, on freedom from AF. The study does not
advocate a “ﬁtness ﬁrst approach.” Beneﬁt from the
“alliance of CRF with weight-loss” is truly over and
above the strategic gain provided by each individually.
Recent studies have demonstrated the beneﬁcial effect
of weight and risk factor management on long-term
freedom from AF (4,5). In summary, we strongly advo-
cate a multimodal approach to lifestyle modiﬁcation. A
structured exercise program to increase CRF should be
an integral component of the management strategy for
AF, particularly in the strategy of rhythm control.Rajeev K. Pathak, MBBS
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Risk Estimator App
From Concept to the Current StateInitial incorporation of the 2013 Blood Cholesterol
Guidelines (1) into clinical practice came with a
particular challenge. Providers were asked to assess
atherosclerotic cardiovascular disease (ASCVD) risk
by manually entering data into an electronic spread-
sheet, using the Omnibus Risk Estimator (2). Not only
was this an impractical solution for nearly all pro-
viders at the point of care, it also severely limited
patients’ ability to engage in risk assessment.
The solution was obvious, we needed a point-of-
care tool that would allow providers the ability to
easily calculate 10-year ASCVD risk, and although
such a stand-alone tool would certainly be valuable,
we recognized that this represented an opportunity to
do so much more. This, in essence, is the history of
the ASCVD risk estimator application software (app).
On February 10, 2014, the ASCVD risk estimator
was made available for free by the American
College of Cardiology and American Heart Associa-
tion, both on the internet and as an app on iTunes
